Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight. 2017 09 21; 2(18).
View in:
PubMed
subject areas
Animals
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Head and Neck Neoplasms
Heterografts
Humans
Immunotherapy
Killer Cells, Natural
Macrophages
Mice
Mice, Inbred C3H
Programmed Cell Death 1 Receptor
Toll-Like Receptor 7
Toll-Like Receptor 9
Tumor Microenvironment
authors with profiles
Ezra Cohen